Slovenian Journal of Public Health (Apr 2020)
Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia
- Vukićević Đurđa,
- Rochau Ursula,
- Savić Aleksandar,
- Schaffner Monika,
- Jevđević Milica,
- Stojkov Igor,
- Sroczynski Gaby,
- Willenbacher Wolfgang,
- Jahn Beate,
- Siebert Uwe
Affiliations
- Vukićević Đurđa
- UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060Austria
- Rochau Ursula
- UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060Austria
- Savić Aleksandar
- University of Novi Sad, Faculty of Medicine, Clinical Center of Vojvodina, Clinic for Hematology, Serbia
- Schaffner Monika
- UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060Austria
- Jevđević Milica
- UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060Austria
- Stojkov Igor
- UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060Austria
- Sroczynski Gaby
- UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060Austria
- Willenbacher Wolfgang
- Medical University, Internal Medicine V, Hematology and Oncology, Innsbruck, Austria
- Jahn Beate
- UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060Austria
- Siebert Uwe
- Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL - Center for Personalized Cancer Medicine, Innsbruck, Austria
- DOI
- https://doi.org/10.2478/sjph-2020-0011
- Journal volume & issue
-
Vol. 59,
no. 2
pp. 83 – 91
Abstract
Evidence on long-term effectiveness and cost effectiveness of treatment sequences for multiple myeloma (MM) is sparse. We used published data and country-specific data to assess the cost effectiveness of four-line treatment sequences for elderly transplant-ineligible patients with MM in Serbia.
Keywords
- multiple myeloma
- sequential treatment
- long-term effectiveness
- cost effectiveness
- multipli mielom
- zaporedno zdravljenje
- dolgoročna uspešnost
- stroškovna učinkovitost
